Worldwide Onychomycosis (Tinea Unguium) Drug Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026
- PRO4493093
- 139 Pages
- May 2021
- Pharmaceuticals
Geographically, the global Onychomycosis (Tinea Unguium) Drug market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.
North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Onychomycosis (Tinea Unguium) Drug market in North America.
Significant participants active in the global Onychomycosis (Tinea Unguium) Drug market include: Johnson & Johnson, Galderma, Qilu Pharmaceutical, GSK, Kaken Pharmaceutical, Novartis, Pfizer, Letai, Xiuzheng Pharmaceutical, Valeant Pharma...
Global Onychomycosis (Tinea Unguium) Drug Market Segmentation:
Onychomycosis (Tinea Unguium) Drug market, by Onychomycosis (Tinea Unguium) Drug type:
External
Oral
…
Onychomycosis (Tinea Unguium) Drug market, by Application:
Age above 50
Age 18-50
Age under 18
…
Onychomycosis (Tinea Unguium) Drug Market Research Report 2014-2026, by region:
North America
The U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Pan Asia Pacific
China
Japan
South Korea
South East Asia Region
India
Australia
Middle East and Africa
Saudi Arabia
UAE
Qatar
Egypt
Nigeria
South Africa
Rest of MEA
The database is running updated by a group of research experts to always reflect the latest trends and information.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Onychomycosis (Tinea Unguium) Drug by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Onychomycosis (Tinea Unguium) Drug Market-Segmentation
4.1 By Type
4.1.1 External
4.1.2 Oral
4.2 By End-User/Application Industry
4.2.1 Age above 50
4.2.2 Age 18-50
4.2.3 Age under 18
4.3 By Geography
4.3.1 North America Onychomycosis (Tinea Unguium) Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Onychomycosis (Tinea Unguium) Drug Production from 2014-2020
4.3.1.2 North America Onychomycosis (Tinea Unguium) Drug Consumption from 2014-2020
4.3.1.3 North America Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2020
4.3.1.4 North America Onychomycosis (Tinea Unguium) Drug Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Onychomycosis (Tinea Unguium) Drug Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Onychomycosis (Tinea Unguium) Drug Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Onychomycosis (Tinea Unguium) Drug Participants Value ($) and Market Share (%) in 2019
4.3.2 Europe Onychomycosis (Tinea Unguium) Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Onychomycosis (Tinea Unguium) Drug Production from 2014-2020
4.3.2.2 Europe Onychomycosis (Tinea Unguium) Drug Consumption from 2014-2020
4.3.2.3 Europe Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2020
4.3.2.4 Europe Onychomycosis (Tinea Unguium) Drug Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Onychomycosis (Tinea Unguium) Drug Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Onychomycosis (Tinea Unguium) Drug Participants Value ($) and Market Share (%) in 2019
4.3.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Production from 2014-2020
4.3.3.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption from 2014-2020
4.3.3.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Onychomycosis (Tinea Unguium) Drug Participants Value ($) and Market Share (%) in 2019
4.3.4 Latin America Onychomycosis (Tinea Unguium) Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Onychomycosis (Tinea Unguium) Drug Production from 2014-2020
4.3.4.2 Latin America Onychomycosis (Tinea Unguium) Drug Consumption from 2014-2020
4.3.4.3 Latin America Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2020
4.3.4.4 Latin America Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Onychomycosis (Tinea Unguium) Drug Participants Value ($) and Market Share (%) in 2019
4.3.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Production from 2014-2020
4.3.5.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption from 2014-2020
4.3.5.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Onychomycosis (Tinea Unguium) Drug Participants Value ($) and Market Share (%) in 2019
5. Competitive Intelligence – Company Profiles
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Galderma
5.2.1 Galderma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Galderma Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Qilu Pharmaceutical
5.3.1 Qilu Pharmaceutical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Qilu Pharmaceutical Sales, Growth Rate and Global Market Share from 2014-2020
5.4 GSK
5.4.1 GSK Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 GSK Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Kaken Pharmaceutical
5.5.1 Kaken Pharmaceutical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Kaken Pharmaceutical Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Novartis
5.6.1 Novartis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Novartis Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Pfizer
5.7.1 Pfizer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Pfizer Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Letai
5.8.1 Letai Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Letai Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Xiuzheng Pharmaceutical
5.9.1 Xiuzheng Pharmaceutical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Xiuzheng Pharmaceutical Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Valeant Pharma
5.10.1 Valeant Pharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Valeant Pharma Sales, Growth Rate and Global Market Share from 2014-2020
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of the Global Onychomycosis (Tinea Unguium) Drug Market from 2021-2026
7.1 Future Forecast of Global Onychomycosis (Tinea Unguium) Drug Market from 2021-2026 Segment by Region
7.2 Future Forecast of the Global Onychomycosis (Tinea Unguium) Drug Market from 2021-2026 Segment by Types
7.3 Future Forecast of the Global Onychomycosis (Tinea Unguium) Drug Market from 2021-2026 Segment by End-User/Applications
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
9 Disclaimer
Global Onychomycosis (Tinea Unguium) Drug Market Value ($) and Growth Rate of Onychomycosis (Tinea Unguium) Drug from 2014-2026
Global Onychomycosis (Tinea Unguium) Drug Production and Growth Rate Segment by Product Types from 2014-2026F
Global Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate Segment by End-User/Application from 2014-2026E
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Onychomycosis (Tinea Unguium) Drug Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Onychomycosis (Tinea Unguium) Drug Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure External of Onychomycosis (Tinea Unguium) Drug
Figure Oral of Onychomycosis (Tinea Unguium) Drug
Table Global Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Onychomycosis (Tinea Unguium) Drug Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Age above 50 of Onychomycosis (Tinea Unguium) Drug
Figure Age 18-50 of Onychomycosis (Tinea Unguium) Drug
Figure Age under 18 of Onychomycosis (Tinea Unguium) Drug
Table Global Onychomycosis (Tinea Unguium) Drug Production Value ($) by Regions
Table Global Onychomycosis (Tinea Unguium) Drug Production Value Share by Regions
Table Global Onychomycosis (Tinea Unguium) Drug Production by Regions
Table Global Onychomycosis (Tinea Unguium) Drug Production Share by Regions
Table Global Onychomycosis (Tinea Unguium) Drug Consumption by Regions
Table Global Onychomycosis (Tinea Unguium) Drug Consumption Share by Regions
Figure North America Onychomycosis (Tinea Unguium) Drug Production and Growth Rate from 2014-2020
Figure North America Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate from 2014-2020
Table North America Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2020
Table North America Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Type from 2019-2020
Table North America Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Application from 2019-2020
Table North America Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Onychomycosis (Tinea Unguium) Drug Participants Value ($) and Market Share (%) in 2019
Figure Europe Onychomycosis (Tinea Unguium) Drug Production and Growth Rate from 2014-2020
Figure Europe Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate from 2014-2020
Table Europe Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2020
Table Europe Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Type from 2019-2020
Table Europe Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Application from 2019-2020
Table Europe Onychomycosis (Tinea Unguium) Drug Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Onychomycosis (Tinea Unguium) Drug Participants Value ($) and Market Share (%) in 2019
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Production and Growth Rate from 2014-2020
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2020
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Onychomycosis (Tinea Unguium) Drug Participants Value ($) and Market Share (%) in 2019
Figure Latin America Onychomycosis (Tinea Unguium) Drug Production and Growth Rate from 2014-2020
Figure Latin America Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate from 2014-2020
Table Latin America Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2020
Table Latin America Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Onychomycosis (Tinea Unguium) Drug Participants Value ($) and Market Share (%) in 2019
Figure Middle East & Africa Onychomycosis (Tinea Unguium) Drug Production and Growth Rate from 2014-2020
Figure Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2020
Table Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Onychomycosis (Tinea Unguium) Drug Participants Value ($) and Market Share (%) in 2019
Table Johnson & Johnson Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Johnson & Johnson Sales and Growth Rate from 2014-2020
Figure Johnson & Johnson Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Galderma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Galderma Sales and Growth Rate from 2014-2020
Figure Galderma Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Qilu Pharmaceutical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Qilu Pharmaceutical Sales and Growth Rate from 2014-2020
Figure Qilu Pharmaceutical Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table GSK Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure GSK Sales and Growth Rate from 2014-2020
Figure GSK Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Kaken Pharmaceutical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Kaken Pharmaceutical Sales and Growth Rate from 2014-2020
Figure Kaken Pharmaceutical Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Novartis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Novartis Sales and Growth Rate from 2014-2020
Figure Novartis Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Pfizer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Pfizer Sales and Growth Rate from 2014-2020
Figure Pfizer Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Letai Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Letai Sales and Growth Rate from 2014-2020
Figure Letai Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Xiuzheng Pharmaceutical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Xiuzheng Pharmaceutical Sales and Growth Rate from 2014-2020
Figure Xiuzheng Pharmaceutical Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Valeant Pharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Valeant Pharma Sales and Growth Rate from 2014-2020
Figure Valeant Pharma Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Onychomycosis (Tinea Unguium) Drug Value ($) and Growth Rate Forecast by Regions (2021-2026)
Table Global Onychomycosis (Tinea Unguium) Drug Production and Growth Rate Forecast by Regions (2021-2026)
Table Global Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate Forecast by Regions (2021-2026)
Table Global Onychomycosis (Tinea Unguium) Drug Production and Growth Rate Forecast by Types (2021-2026)
Table Global Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
